Rose Jose, PharmD, chief operating officer, Outpatient and Specialty Pharmacy Services, LifeBridge Health, Baltimore, Maryland
Jose, 38, earned her doctorate in pharmacy in 2004 and became a licensed pharmacist at 23 years old. In 2008, she assumed a role in pharmacy administration at the University of Maryland Medical System in Baltimore. In 2012, she joined LifeBridge Health as the director of outpatient pharmacy services, where she is now the chief operating officer of outpatient and specialty pharmacy services.
MHE: Why did you choose your profession?
Jose: I decided to pursue pharmacy after my father and I were in a serious car accident when I was a young teenager. I was hospitalized and wheelchair bound for months. My mother, a cardiothoracic nurse, took amazing care of us once we came home from the hospital. When my mom had to go back to work, I took on additional responsibilities around the house, including giving my dad each of his many medications at the right time. I felt that I made a real difference in my dad’s recovery and wanted to continue making a positive impact in the lives of people who need it most.
MHE: What has been your biggest learning experience in the industry? What did it teach you?
Jose: Entering the pharmaceutical industry at 23 years old was a challenge. When you’re young in the profession, you’re sometimes perceived as “green” and need to establish credibility to gain your peers’ respect. I had to work extra hard to earn trust from my colleagues over time, and that that gave me confidence in my abilities as I took on more advanced positions and leadership roles.
MHE: What change would you like to see in healthcare in the next 5 to 10 years?
Jose: I’m fascinated by the rapid advancements in genetic testing. Pharmacogenomics presents an incredible opportunity for personal medication management, and I’d like to see how we can leverage the widespread availability of testing to improve patient outcomes. A patient’s prescription could be tailored to their individual DNA test results, meaning we eliminate waste, decrease side effects, and create optimal therapeutic outcomes.
MHE: If you could sit down to dinner with anyone involved in healthcare who would it be?
Jose: CEO of GlaxoSmithKline Emma Walmsley. She’s fascinating for many reasons. She was named Fortune Magazine’s most powerful international woman in business and is the first woman to run a major pharmaceutical company. I’d like to learn about her perspective of the drug industry and other hot topics such as drug pricing transparency or lowering drug prices. One of her main focuses is on drug development. I’d like to hear about her outlook on vaccines in development for conditions such as cancer, HIV, and other illnesses that affect so many people, and how these advances can shape healthcare’s future.
Karen Appold is a medical writer in Lehigh Valley, Pennsylvania.